Education
About Us
Working with TipRanks
Follow Us
Virax Biolabs Group Ltd. Class A (VRAX)
NASDAQ:VRAX
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 6.33K | $ 156.42K | - | $ 0.00 | $ 123.82K |
| Gross Profit | $ -53.07K | $ 50.59K | - | $ 0.00 | $ -9.43K |
| Operating Income | $ -6.16M | $ -6.50M | $ -5.73M | $ -1.73M | $ -644.54K |
| EBITDA | $ -5.80M | $ -6.61M | $ -5.44M | $ -750.00 | $ 0.00 |
| Net Income | $ -6.06M | $ -6.73M | $ -5.46M | $ -1.71M | $ -650.98K |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 4.23M | $ 3.59M | $ 9.35M | $ 21.76K | $ 17.62K |
| Total Assets | $ 6.43M | $ 5.48M | $ 9.81M | $ 48.71K | $ 94.12K |
| Total Debt | $ 377.00K | $ 224.30K | $ 146.25K | - | $ 179.48K |
| Net Debt | $ -3.85M | $ -3.36M | $ -9.21M | - | $ 161.86K |
| Total Liabilities | $ 964.75K | $ 345.19K | $ 908.40K | $ 1.25M | $ 871.43K |
| Stockholders' Equity | $ 5.70M | $ 5.37M | $ 9.13M | $ -974.58K | $ -596.18K |
| Cash Flow | |||||
| Free Cash Flow | $ -5.17M | $ -7.41M | $ -4.36M | $ -809.07K | $ -590.19K |
| Operating Cash Flow | $ -4.56M | $ -6.25M | $ -4.18M | $ -809.07K | $ -590.19K |
| Investing Cash Flow | $ -603.89K | $ -1.16M | $ -178.40K | $ 0.00 | $ 0.00 |
| Financing Cash Flow | $ 5.81M | $ 1.65M | $ 13.69M | $ 813.21K | $ 585.20K |
Virax Biolabs Group Ltd. Class A Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.